Arun Mistry

795 total citations · 2 hit papers
8 papers, 569 citations indexed

About

Arun Mistry is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Epidemiology. According to data from OpenAlex, Arun Mistry has authored 8 papers receiving a total of 569 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Psychiatry and Mental health, 4 papers in Pediatrics, Perinatology and Child Health and 2 papers in Epidemiology. Recurrent topics in Arun Mistry's work include Epilepsy research and treatment (5 papers), Neonatal and fetal brain pathology (3 papers) and Pharmacological Effects and Toxicity Studies (2 papers). Arun Mistry is often cited by papers focused on Epilepsy research and treatment (5 papers), Neonatal and fetal brain pathology (3 papers) and Pharmacological Effects and Toxicity Studies (2 papers). Arun Mistry collaborates with scholars based in United Kingdom, United States and Germany. Arun Mistry's co-authors include Glenn Morrison, Michael Lock, Bradley S. Galer, Gail Farfel, Kelly G. Knupp, Linda Laux, Anupam Agarwal, Stéphane Auvin, Rima Nabbout and J. Helen Cross and has published in prestigious journals such as The Lancet, Journal of Bone and Mineral Research and European Urology.

In The Last Decade

Arun Mistry

8 papers receiving 549 citations

Hit Papers

Fenfluramine hydrochloride for the treatment of seizures ... 2019 2026 2021 2023 2019 2019 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial
    2019 249 citations Lieven Lagae, Joseph Sullivan et al. The Lancet profile →
  2. Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens
    2019 180 citations Rima Nabbout, Arun Mistry et al. JAMA Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arun Mistry United Kingdom 6 416 281 158 116 73 8 569
Mustafa Kömür Türkiye 11 119 0.3× 125 0.4× 45 0.3× 26 0.2× 30 0.4× 49 376
Roberto Ramírez United States 9 212 0.5× 128 0.5× 164 1.0× 38 0.3× 58 0.8× 18 520
Chiara Bedetti Italy 10 157 0.4× 119 0.4× 63 0.4× 32 0.3× 45 0.6× 18 303
Fabienne Dietrich Alber Switzerland 8 228 0.5× 287 1.0× 53 0.3× 113 1.0× 81 1.1× 9 504
Marc Boel Belgium 11 298 0.7× 206 0.7× 163 1.0× 107 0.9× 71 1.0× 17 454
Felix von Podewils Germany 18 756 1.8× 571 2.0× 339 2.1× 65 0.6× 61 0.8× 64 1.0k
Hadassah Goldberg‐Stern Israel 12 255 0.6× 143 0.5× 91 0.6× 79 0.7× 49 0.7× 18 380
Paola De Liso Italy 13 244 0.6× 189 0.7× 98 0.6× 67 0.6× 85 1.2× 25 464
Elaine Hughes United Kingdom 13 406 1.0× 291 1.0× 206 1.3× 126 1.1× 146 2.0× 30 730
R. Korte Netherlands 12 210 0.5× 185 0.7× 86 0.5× 30 0.3× 105 1.4× 18 464

Countries citing papers authored by Arun Mistry

Since Specialization
Citations

This map shows the geographic impact of Arun Mistry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arun Mistry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arun Mistry more than expected).

Fields of papers citing papers by Arun Mistry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arun Mistry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arun Mistry. The network helps show where Arun Mistry may publish in the future.

Co-authorship network of co-authors of Arun Mistry

This figure shows the co-authorship network connecting the top 25 collaborators of Arun Mistry. A scholar is included among the top collaborators of Arun Mistry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arun Mistry. Arun Mistry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Glorieux, Francis H., Bente Langdahl, Roland Chapurlat, et al.. (2024). Setrusumab for the treatment of osteogenesis imperfecta: 12-month results from the phase 2b asteroid study. Journal of Bone and Mineral Research. 39(9). 1215–1228. 9 indexed citations
2.
Bober, Michael B., Cathleen Raggio, Lena Lande Wekre, et al.. (2023). The patient clinical journey and socioeconomic impact of osteogenesis imperfecta: a systematic scoping review. Orphanet Journal of Rare Diseases. 18(1). 34–34. 13 indexed citations
3.
Lagae, Lieven, Joseph Sullivan, Kelly G. Knupp, et al.. (2019). Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial. The Lancet. 394(10216). 2243–2254. 249 indexed citations breakdown →
4.
Nabbout, Rima, Arun Mistry, Sameer M. Zuberi, et al.. (2019). Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens. JAMA Neurology. 77(3). 300–300. 180 indexed citations breakdown →
5.
Zuberi, Sameer M., J. Helen Cross, Anand Iyer, et al.. (2019). Fenfluramine HCl Provides Long-Term Clinically Meaningful Reduction in Seizure Frequency: Results of an Open-Label Extension Study. Epilepsy & Behavior. 101. 106790–106790. 1 indexed citations
6.
Polster, Tilman, Lieven Lagae, Joseph Sullivan, et al.. (2018). IP 1184. ZX008 (Fenfluramine) in Dravet’s Syndrome: First Results of a Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial. Neuropediatrics. 3 indexed citations
7.
Nabbout, Rima, Stéphane Auvin, Catherine Chiron, et al.. (2017). Development and content validation of a preliminary core set of patient- and caregiver-relevant outcomes for inclusion in a potential composite endpoint for Dravet Syndrome. Epilepsy & Behavior. 78. 232–242. 53 indexed citations
8.
Chapple, Christopher R., Vik Khullar, Roberto Mario Scarpa, et al.. (2007). Treatment Outcomes in the STAR Study: A Subanalysis of Solifenacin 5 mg and Tolterodine ER 4 mg. European Urology. 52(4). 1195–1203. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mustafa Kömür Breakdown of academic impact, for papers by Roberto Ramírez Breakdown of academic impact, for papers by Chiara Bedetti Breakdown of academic impact, for papers by Fabienne Dietrich Alber Breakdown of academic impact, for papers by Marc Boel Breakdown of academic impact, for papers by Felix von Podewils Breakdown of academic impact, for papers by Hadassah Goldberg‐Stern Breakdown of academic impact, for papers by Paola De Liso Breakdown of academic impact, for papers by Elaine Hughes Breakdown of academic impact, for papers by R. Korte
Rankless by CCL
2026